The report includes the revenue generated from the sales of vaccines used for the prevention of various animal diseases. Recent advancements and developments in the animal vaccines market have enhanced the efficiency of these drugs. Drivers, restraints, and opportunities are explained in detail to understand the market dynamics. Key strategies adopted by the potential market leaders to facilitate effective planning and decision-making are also discussed.

Animal model is a non-human species utilized in medical research as it shows related aspects of diseases and disorders that are found in humans. It is used to test the efficacy of the treatment cycle and effectiveness of a drug for specific disease condition. The report provides market dynamics and trends related to the animal model market. The study estimates the revenue generated from the sales of animal model types. The valuations comprise revenue generated from animal model types such as rat, mice, guinea pigs, rabbits, and others.

An ultrasonic sensor works by releasing sound waves at high frequency for humans to hear, and when sound is reflected, it calculates the distance based on the time it took to travel. It is widely used in many applications such as presence detection, stacking height control, robotic sensing, liquid level control, loop control, full detection, through-beam detection for high-speed counting, irregular parts detection for hoppers and feeder bowls, 45° deflection, thread or wire break detection, and contouring using ultrasonic systems.

The global urology care devices and platforms market has the presence of various key medical device companies operating in the market. The major medical device companies operating in the market include Baxter International Inc., Olympus Corporation, Boston Scientific Corporation, Becton, Dickinson and Company, and Medtronic plc. The companies offer a diverse product portfolio, including dialysis devices, lasers and lithotripsy devices, and consumables such as guidewires and catheters, stents, and biopsy devices.

产业痛点：目前我国医药产业总体在政策导向下面临转型压力，而我国传统医药产 业痛点主要集中于经营模式过于单一，线上监管滞后以及针对供应链管理的不足。 亟需医药产业互联网协同创新，优化信息流。 

2020 年，新冠疫情席卷全球，对各经济体的生产制造、消费投资、社会治理、民众信心等造成全方位冲击，全球经济陷入“大萧条”以来最严重衰退，预计 2020 年全球经济萎缩 3.5%。我国统筹疫情防控和经济社会发展取得重大成果，经济运行持续稳定恢复，就业民生保障有力，经济社会发展主要目标任务完成情况好于预期，初步核算，2020 年国内生产总值比上年增长2.3%。政策方面，多部委出台疫情防控及配套政策，国家药品集采有序推进，国家医保制度不断完善，医疗监管政策全面趋严，多政策促“互联网+医疗健康”向纵深发展，医保支付结算服务持续优化。

上周中信医药生物行业指数上涨2.62%，跑赢沪深300指数5.76个百分点。 各子行业中，涨幅最大的板块为医疗服务+9.80%、跌幅最大的板块为医药 流通-2.13%。上周五，医药行业市场表现回暖。国家组织人工关节集中带量采购中选结 果公示，相比之前冠脉支架采购降价情况较为温和，降价结果好于市场预 期。

The non-invasive liquid biopsy technique uses samples such as stool, urine, saliva, and other samples, which are extracted without inserting any medical device into the patient’s body. These samples help healthcare professionals to identify biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), circulating messenger RNA (mRNA), circulating microRNA (miRNA), DNA methylation-based biomarkers, exosomes, and extracellular vesicles (EVs). Extensive research is being conducted worldwide for the discovery and presence of novel biomarkers in these samples, which is expected to support the healthcare continuum to conduct liquid biopsy without penetrating any minimally invasive device into the patient’s body.

9 月14 日，广东省药品交易中心有限公司公布集团带量采购文件，开展清开灵等58个药品带量采购工作，对基本医保药品目录内，用量大、采购金额高的58 个药品，在联盟地区开展带量采购。联盟地区包括广东、山西、河南、海南、宁夏、青海、新疆7 省级行政区，是首次大范围的中成药集采探索。我们认为：一方面，中药的资源属性决定其降幅相较于化药品种有望更加缓和。与化药的生产成本相对固定所不同，中药上游对应的是中药种植业，由于气候、自然灾害等不可控因素的存在，其生产成本波动性较大。另一方面，集采的目的是打掉中间环节的损耗，国家近年来大力鼓励中医药的发展，是希望以合理的价格为人民提供高质量的中医药产品和服务，而一味追求降价将伤害中药企业的积极性，这与国家政策的初衷相悖。基于此，我们预计未来政策力度不会太激进，此次广东联盟地区集采文件规则缓和，也为未来中成药的集采提供了一个范式，因此无需对中成药的集采过分悲观。独家品种有望匹配到更加优良的中标规则，推荐关注：独家品种丰富的特色中药企业以岭药业、中国中药、云南白药。